ANVS

Annovis Bio Inc

• Benzinga·21h ago

  Annovis Bio Closes Underwritten Public Offering Raising ~$10M In Gross Proceeds; Financing Secures Path To First NDA Submission For Buntanetap

• TipRanks·23h ago

  Annovis Bio Prices Registered Direct Offering to Fund Trials

• Benzinga·1d ago

  12 Health Care Stocks Moving In Thursday's Intraday Session

• NASDAQ·1d ago

  Annoivs Bio Launches $10M Underwritten Offering

• NASDAQ·4d ago

  Monday 4/6 Insider Buying Report: ANVS, VALE

• NASDAQ·4d ago

  Annovis Strengthens Patent Portfolio With Buntanetap, Stock Up

• Benzinga·4d ago

  12 Health Care Stocks Moving In Monday's Pre-Market Session

• TipRanks·04/04 02:02

  Top Insider Makes Bold Multi-Million Dollar Move Into Annovis Bio

• TipRanks·04/02 11:54

  Annovis Bio secures U.S. patent for buntanetap

• Benzinga·04/02 11:31

  Annovis Bio Issued New U.S. Patent For Prevention And Treatment Of Neurological Injuries From Brain Infections

• Benzinga·03/25 21:23

  Annovis Bio Mark Guerin Steps Down As CFO Effective March 23, 2026; CEO Maria Maccecchini To Serve As Acting CFO Until Replacement Is Identified

• TipRanks·03/19 11:56

  Annovis Bio enters partnership with NeuroRPM

• Benzinga·03/19 11:35

  NeuroRPM's Wearable Platform To Be Used For Digital Biomarker Monitoring In Annovis Bio's ANVS-25002 Open-Label Parkinson's Disease Clinical Study

• TipRanks·03/18 18:30

  Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY) and Annovis Bio (ANVS)

• Seeking Alpha·03/16 11:42

  Annovis Bio GAAP EPS of -$1.40